Migraine attacks often bring nausea, light and sound sensitivity, and lost function, and can last hours to days, according to the American Academy of Neurology (AAN). Getting a prescription for rescue or preventive migraine medicine in person often means a long wait: AMN Healthcare's 2025 survey of 15 metro areas found new-patient family medicine waits averaged 23.5 days (31 days across all surveyed specialties), and a national study found in-person visits average 121 minutes. By message, a physician can review your headache history and prescribe non-controlled treatments without locking you into a monthly subscription.

On FutureClinic, a specific doctor reads your whole case by message and sends a written plan with a Human Signature: a short live-recorded video or voice note. No form is approved in bulk. Your doctor can help with other problems in their specialty, and every FutureClinic doctor you see works from one medical record. Real care takes hours, not seconds: replies typically come within a few hours, and almost always the same day or the next. Every clinician is a physician (MD, DO or MBBS), never a nurse practitioner or physician assistant.

What does messaging the same doctor over months do for migraine?

Messaging the same doctor time after time in the same chat, however long in between, builds trust and lets you try treatments together and track progress. About 30% of people on a triptan have an insufficient response and may benefit from a second triptan or, if certain criteria are met, a gepant, according to the 2021 American Headache Society (AHS) statement, which also advises a non-oral form when attacks bring severe nausea or vomiting, while the August 2026 AAN/AHS guideline judges most preventives over 8 to 12 weeks.

FutureClinic sells no medicine, and your doctor earns nothing extra for any prescription or test, so they never upsell a drug or lab panel. With no house formulary, your doctor can prescribe whichever brand or generic fits you to the pharmacy you choose, if your doctor decides it's right for you.

AI migraine treatment: how a doctor diagnoses and manages migraine by message

The National Institute of Neurological Disorders and Stroke (NINDS) notes that doctors diagnose migraine from your history and exam without routine MRI or CT scans, and AHS Choosing Wisely advises against neuroimaging for stable headaches meeting migraine criteria (at least five 4-to-72-hour attacks with typical migraine features under ICHD-3; chronic migraine is 15 or more headache days a month for over 3 months, with migraine features on at least 8 of those days, per AAN). First, a doctor-trained AI assistant gathers your headache diary, medicine days, past treatments, blood pressure, heart history, and pregnancy plans. It never gives medical advice; you confirm a summary before your doctor replies.

Which rescue medicines stop a migraine attack?

Under AHS (2021) and NINDS guidance, mild to moderate attacks may respond to NSAIDs (naproxen, ibuprofen), acetaminophen, caffeine combinations, and nausea drugs like metoclopramide. Moderate or severe attacks use migraine-specific drugs at the first sign of pain, if your doctor decides it's right for you:

• Triptans: Sumatriptan (Imitrex, 25 to 100 mg) and rizatriptan (Maxalt, 5 or 10 mg; 5 mg with propranolol) come as tablets, disintegrating tablets, nasal sprays, and sumatriptan injections. Contraindications include coronary disease, stroke, TIA, uncontrolled high blood pressure, hemiplegic/basilar migraine, and vascular or ischemic bowel disease; labels warn of serotonin syndrome with SSRIs, SNRIs, tricyclics, or MAO inhibitors. Triptan-naive patients with multiple heart risk factors need an in-person heart evaluation first.
• Gepants and excluded drugs: Frequent use of ubrogepant (Ubrelvy) or rimegepant (Nurtec ODT) does not appear to cause medication-overuse headache, and gepants appeared safe in trials for people with stable heart disease, though benefit and risk are weighed for each patient (AHS 2021); zavegepant (Zavzpret) is a gepant nasal spray; labels warn of high blood pressure, Raynaud's phenomenon, and strong CYP3A4 inhibitors. FutureClinic doctors don't prescribe controlled medicines like lasmiditan (Reyvow, Schedule V) or opioids. AHS advises against opioid or butalbital-containing medicines as first-line treatment.

When do guidelines recommend preventive migraine medicines?

The August 2026 AAN/AHS guideline recommends offering prevention for 4 or more migraine or moderate-to-severe headache days a month, substantial disability, or medication overuse (prescription attack drugs over 9 days/month, or nonspecific pain relievers over 14 days/month). If your doctor decides it's right for you:

• Daily pills: Propranolol (Inderal LA), topiramate (Topamax, 100 mg/day), and divalproex (Depakote) have high-confidence evidence; amitriptyline, metoprolol, and telmisartan are lower-confidence episodic options. Avoid topiramate and divalproex if possible in patients who could become pregnant (divalproex is contraindicated in pregnancy and without effective contraception; topiramate above 200 mg/day reduces hormonal contraceptive effectiveness). Doctors can order blood bicarbonate (topiramate) or liver tests (divalproex) at discounted prices.
• CGRP preventives: Named first-line by AHS (2024) without failing older drugs first, these include oral atogepant (Qulipta) and rimegepant (Nurtec ODT), and self-injected erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality). A 2026 study found 95.3% of plans covered at least one CGRP drug, though rules requiring older pills first were largely still in place, and a 2023 study of 47 managed-care organizations found prior authorization policies at 85% to 96% of them, depending on the antibody; FutureClinic helps get prior authorizations when insurance needs one. Intravenous eptinezumab (Vyepti) and onabotulinumtoxinA (Botox) require an in-person clinic.